SYRE
Spyre Therapeutics Inc.
85.70$
-1.6%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +368.4% | +48.3% | +88.6% | +17.7% | +207.5% | +10.5% | +58.2% | -0.6% | -52.5% | +0.0% | -1,187.4% | |
| – | +421.8% | – | – | – | – | +13.8% | +28.5% | -11.5% | +261.1% | +74.6% | -16.1% | |
| – | -5,226.9% | – | -113.7% | – | -1.3% | -135.8% | – | -400.2% | – | – | – | |
| – | +14.9% | +1.9% | +192.0% | -31.8% | +253.6% | +186.9% | -86.6% | -93.4% | -100.0% | – | – | |
| – | +1,716.3% | +202.8% | +85.3% | -32.4% | -88.6% | +337.3% | +197.5% | – | – | – | -59.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | -18.0% | -96.2% | -100.0% | – | |
| – | +647.5% | +18.5% | -75.3% | +367.3% | +15.2% | +135.1% | -99.1% | +2,963.7% | +746.0% | +13.8% | -24.8% | |
| – | – | -31.1% | -290.1% | – | -133.3% | – | -205.3% | – | +686.2% | -165.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.